1-1 of 1
Authors: Jianjun Peng
Sort by
Journal Article
A phase IV study to evaluate the safety of fruquintinib in Chinese patients in real-world clinical practice
Jin Li and others
The Oncologist, Volume 29, Issue 8, August 2024, Pages e1012–e1019, https://doi.org/10.1093/oncolo/oyae073
Published: 20 April 2024
Advertisement
Advertisement